Terms ending in 2033
Every in-force patent on Gilead Sciences, Inc.'s record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,284,323 | Naphthalene Acetic Acid Derivatives Against HIV Infection In force · Medium confidence | Gilead Sciences, Inc. | In force | Medium confidence | |
| US 9,376,392 | 2- (TERT - Butoxy) -2- (7 -Methylquinolin- 6 - Yl) Acetic Acid Derivatives for Treating Aids In force · Medium confidence | Gilead Sciences, Inc. | In force | Medium confidence | |
| US 8,742,126 | Apoptosis Signal-Regulating Kinase Inhibitor In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 9,254,284 | Apoptosis Signal-Regulating Kinase Inhibitor In force · Medium confidence | Gilead Sciences, Inc. | In force | Medium confidence | |
| US 9,333,197 | Apoptosis Signal-Regulating Kinase Inhibitor In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 9,750,730 | Apoptosis Signal-Regulating Kinase Inhibitor In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 9,873,682 | Apoptosis Signal-Regulating Kinase Inhibitor In force · Medium confidence | Gilead Sciences, Inc. | In force | Medium confidence | |
| US 10,508,100 | Apoptosis Signal-Regulating Kinase Inhibitor In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 8,962,610 | Fused Heterocyclic Compounds as Ion Channel Modulators In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 9,988,425 | Immunogens for HIV Vaccination In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| 47 more term ends in 2033 · Pro | |||||
10 of 57 patents shown. Soonest term end first, then patent number.
Pro members see all 57.
50 of these are in force and held by Gilead Sciences, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.